Literature DB >> 3441659

A practical application of Rhame and Sudderth's formula on nosocomial infection surveillance.

M Delgado-Rodríguez1, A Cueto Espinar, R Rodríguez-Contreras Pelayo, R Gálvez Vargas.   

Abstract

We have conducted an epidemiological analysis of the utility of Rhame and Sudderth's formula--establishing a relationship between prevalence, incidence and duration of nosocomial infection--as an effective model in the surveillance of such infection. We carried out a follow-up study in a surgical service of our hospital on a sample of 799 patients admitted between January 1 and June 17, 1983 (24 weeks). We confirmed the condition of steady-state and were able to conclude that the Rhame and Sudderth model can have great utility when cross-sectional studies are performed with an adequate interval. We also concluded that the application of this model is not influenced by the size of the ward or zone of survey.

Entities:  

Mesh:

Year:  1987        PMID: 3441659

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  3 in total

1.  Hospital stay length as an effect modifier of other risk factors for nosocomial infection.

Authors:  M Delgado-Rodríguez; A Bueno-Cavanillas; R López-Gigosos; J de Dios Luna-Castillo; J Guillén-Solvas; O Moreno-Abril; B Rodríguez-Tuñas; A Cueto-Espinar; R Rodríguez-Contreras; R Gálvez-Vargas
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

2.  Preoperative stay as a risk factor for nosocomial infection.

Authors:  A Bueno Cavanillas; R Rodrìguez-Contreras; M Delgado Rodriguez; O Moreno Abril; R López Gigosos; J Guillen Solvas; R Gálvez Vargas
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

3.  Incidence of surgical site infections cannot be derived reliably from point prevalence survey data in Dutch hospitals.

Authors:  A P Meijs; J A Ferreira; S C DE Greeff; M C Vos; M B G Koek
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.